Skip to main content

Table 3 Patient characteristics

From: Comparison of functional and oncological outcomes of innovative “three-port” and traditional “four-port” laparoscopic radical prostatectomy in patients with prostate cancer

 

Overall

Group_A

Group_B

P

Cases

234

112

122

 

pT_stage (%)

0.809

 pT2b

16 (6.8)

8 (7.1)

8 (6.6)

 

 pT2c

125 (53.4)

63 (56.2)

62 (50.8)

 

 pT3a

56 (23.9)

24 (21.4)

32 (26.2)

 

 pT3b

37 (15.8)

17 (15.2)

20 (16.4)

 

Patho_GS (%)

0.638

 3 + 3

16 (6.8)

7 (6.2)

9 (7.4)

 

 3 + 4

70 (29.9)

27 (24.1)

43 (35.2)

 

 4 + 3

100 (42.7)

57 (50.9)

43 (35.2)

 

 4 + 4

3 (1.3)

1 (0.9)

2 (1.6)

 

 4 + 5

30 (12.8)

12 (10.7)

18 (14.8)

 

 5 + 3

7 (3.0)

3 (2.7)

4 (3.3)

 

 5 + 4

8 (3.4)

5 (4.5)

3 (2.5)

 

SurgicalMargin (%)

1

 Negative

159 (67.9)

76 (67.9)

83 (68.0)

 

 Postive

75 (32.1)

36 (32.1)

39 (32.0)

 

BioChemicalRecurrence (%)

1

 Negative

209 (89.3)

100 (89.3)

109 (89.3)

 

 Positive

25 (10.7)

12 (10.7)

13 (10.7)

 

Continence (%)

 Third month

186 (79.5)

92 (82.1)

94 (77.0)

0.423

 Sixth month

196 (83.8)

97 (86.6)

99 (81.1)

0.340

 Twelfth month

206 (88.0)

102 (91.1)

104 (85.2)

0.242